Heart Failure Clinical Trial

Study of the Implantable Cardioverter Defibrillator (ICD) Intracardiac Electrograms

Summary

The purpose of this study is to determine whether waveforms of the intracardiac electrograms, acquired through an ICD, can be used:

to predict malignant ventricular arrhythmias, requiring appropriate ICD therapies, and
to predict progression of heart failure in patients with ICD.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

history of acute MI at least 4 weeks old
non-ischemic LV dysfunction for at least 9 months
who have an EF < or = to 35%
who was resuscitated from sudden cardiac arrest (ventricular tachyarrhythmia)
undergone implantation of an FDA-approved ICD for primary or secondary prevention of SCD

Exclusion Criteria:

inability or unwillingness to provide valid informed consent
pregnancy
any condition other than cardiac disease that was associated with a high likelihood of death during 1 year after enrollment

Study is for people with:

Heart Failure

Estimated Enrollment:

630

Study ID:

NCT00916435

Recruitment Status:

Completed

Sponsor:

Johns Hopkins University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Johns Hopkins University School of Medicine
Baltimore Maryland, 21205, United States
Washington University School of Medicine
Saint Louis Missouri, 63110, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

630

Study ID:

NCT00916435

Recruitment Status:

Completed

Sponsor:


Johns Hopkins University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider